Security key
19249H103
Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS)
CUSIP: 19249H103
Q4 2022 13F Holders as of 31 Dec 2022
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 153,624,096
- Total 13F shares
- 78,672,183
- Share change
- +1,050,393
- Total reported value
- $622,985,097
- Put/Call ratio
- 116%
- Price per share
- $7.92
- Number of holders
- 160
- Value change
- +$2,380,758
- Number of buys
- 79
- Number of sells
- 81
Report period
Q4 2022
Institutions
160
Top holders
10
CHRS full security history
Newer quarter: Q1 2023
Previous quarter: Q3 2022
Coherus Oncology, Inc. SEC filings
Coherus Oncology, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 19249H103
Recent filing periods:
Top shareholders of CHRS - Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
8.5%
|
12,984,843
|
$124,786,000 | — | 30 Sep 2022 | |
| Temasek Holdings (Private) Ltd |
13F
|
Company |
4.8%
|
7,381,116
|
$70,932,525 | — | 30 Sep 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
4%
|
6,125,245
|
$58,864,000 | — | 30 Sep 2022 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
4%
|
6,106,861
|
$58,687,000 | — | 30 Sep 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.4%
|
5,228,701
|
$50,248,000 | — | 30 Sep 2022 | |
| STATE STREET CORP |
13F
|
Company |
3.3%
|
5,105,771
|
$49,066,000 | — | 30 Sep 2022 | |
| Kohlberg Kravis Roberts & Co. L.P. |
13F
|
Company |
2%
|
3,036,076
|
$29,177,000 | — | 30 Sep 2022 | |
| Aristotle Capital Boston, LLC |
13F
|
Company |
1.4%
|
2,141,380
|
$20,579,000 | — | 30 Sep 2022 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
1.2%
|
1,826,111
|
$17,547,000 | — | 30 Sep 2022 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.1%
|
1,667,123
|
$16,021,000 | — | 30 Sep 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.8%
|
1,229,209
|
$11,812,000 | — | 30 Sep 2022 | |
| DISCIPLINED GROWTH INVESTORS INC /MN |
13F
|
Company |
0.74%
|
1,132,096
|
$10,879,000 | — | 30 Sep 2022 | |
| PEREGRINE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.74%
|
1,129,606
|
$10,856,000 | — | 30 Sep 2022 | |
| C WorldWide Group Holding A/S |
13F
|
Company |
0.6%
|
928,464
|
$8,923,000 | — | 30 Sep 2022 | |
| CITIGROUP INC |
13F
|
Company |
0.55%
|
837,696
|
$8,050,000 | — | 30 Sep 2022 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.52%
|
799,950
|
$7,687,000 | — | 30 Sep 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.5%
|
772,222
|
$7,421,000 | — | 30 Sep 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.49%
|
757,124
|
$7,277,000 | — | 30 Sep 2022 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.49%
|
750,000
|
$7,208,000 | — | 30 Sep 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.47%
|
729,437
|
$7,010,000 | — | 30 Sep 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.46%
|
700,997
|
$6,738,000 | — | 30 Sep 2022 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.44%
|
678,103
|
$6,516,000 | — | 30 Sep 2022 | |
| SCOUT INVESTMENTS, INC. |
13F
|
Company |
0.44%
|
669,386
|
$6,433,000 | — | 30 Sep 2022 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.43%
|
662,960
|
$6,371,000 | — | 30 Sep 2022 | |
| Tri Locum Partners LP |
13F
|
Company |
0.41%
|
636,943
|
$6,121,000 | — | 30 Sep 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.41%
|
623,891
|
$5,996,000 | — | 30 Sep 2022 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.39%
|
595,544
|
$5,723,000 | — | 30 Sep 2022 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.37%
|
571,847
|
$5,495,000 | — | 30 Sep 2022 | |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
|
Company |
0.36%
|
549,899
|
$5,285,000 | — | 30 Sep 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.34%
|
517,155
|
$4,970,000 | — | 30 Sep 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.32%
|
492,343
|
$4,732,000 | — | 30 Sep 2022 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.31%
|
473,611
|
$4,552,000 | — | 30 Sep 2022 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.28%
|
431,273
|
$4,145,000 | — | 30 Sep 2022 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.28%
|
430,591
|
$4,145,000 | — | 30 Sep 2022 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.24%
|
369,783
|
$3,554,000 | — | 30 Sep 2022 | |
| Invesco Ltd. |
13F
|
Company |
0.21%
|
315,624
|
$3,033,000 | — | 30 Sep 2022 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.2%
|
311,293
|
$2,991,526 | — | 30 Sep 2022 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.19%
|
297,115
|
$2,855,275 | — | 30 Sep 2022 | |
| Graham Capital Management, L.P. |
13F
|
Company |
0.18%
|
278,770
|
$2,678,000 | — | 30 Sep 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.18%
|
271,068
|
$2,605,000 | — | 30 Sep 2022 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.17%
|
268,836
|
$2,584,000 | — | 30 Sep 2022 | |
| PICTET ASSET MANAGEMENT SA |
13F
|
Company |
0.15%
|
231,792
|
$2,228,000 | — | 30 Sep 2022 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.15%
|
224,306
|
$2,156,000 | — | 30 Sep 2022 | |
| BARCLAYS PLC |
13F
|
Company |
0.13%
|
204,804
|
$1,969,000 | — | 30 Sep 2022 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.13%
|
202,536
|
$1,946,000 | — | 30 Sep 2022 | |
| CM Management, LLC |
13F
|
Company |
0.13%
|
200,000
|
$1,922,000 | — | 30 Sep 2022 | |
| David M. Knott Jr. |
13F
|
Individual |
0.13%
|
200,000
|
$1,922,000 | — | 30 Sep 2022 | |
| EMERALD MUTUAL FUND ADVISERS TRUST |
13F
|
Company |
0.12%
|
191,245
|
$1,838,000 | — | 30 Sep 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.12%
|
189,562
|
$1,822,000 | — | 30 Sep 2022 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.12%
|
187,106
|
$1,798,000 | — | 30 Sep 2022 |
Institutional Holders of Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS) as of Q4 2022
As of 31 Dec 2022,
Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS) was held by
160 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
78,672,183 shares.
The largest 10 holders included
BlackRock Inc., Temasek Holdings (Private) Ltd, STATE STREET CORP, JPMORGAN CHASE & CO, ALLIANCEBERNSTEIN L.P., VANGUARD GROUP INC, Kohlberg Kravis Roberts & Co. L.P., Aristotle Capital Boston, LLC, AMERIPRISE FINANCIAL INC, and CITADEL ADVISORS LLC.
This page lists
160
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
168
Q4 2022 holders
160
Holder diff
-8
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 Value $ | Q4 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.